MedPath

Skin benefit study of Test product

Completed
Conditions
Mukhadushika
Registration Number
CTRI/2021/07/035266
Lead Sponsor
Unilever Industries Pvt Ltd
Brief Summary

Study will be conducted to assess the efficacyof test product in imparting   skin benefits.   Afterconsenting and qualifying the inclusion and exclusion criteria subjects will beenrolled into the study. Post wash out period, test product will be dispensedto subjects as per randomization and post base line assessment subjects will beinstructed to use the product twice a day and evaluation assessments will be doneat different times points over a period of 5 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
240
Inclusion Criteria
  • 1.Female subject between 18-35 years of age.
  • 2.Each subject with mild to moderate acne and with oily/ acne prone skin 3.Subject who agree not to use of any other skin lightening product/treatment/soap bar/home remedy/bleaching on their face during the study period 4.Subjects who agree not use any face packs, facials, make up and sunscreens on their face during the study period 5.Subject to agree not to carry out bleaching or any other skin care procedures on face during the study period.
Exclusion Criteria
  • 1.Subjects with known skin condition that may impact the assessment 2.Subject with any other signs of significant local irritation or skin disease.
  • 3.Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data.
  • 4.Subject having chronic illness or had major surgery in the last year.
  • 5.Subjects with dry to very dry skin, which will interfere with the test assessments.
  • 6.Subjects undergoing any treatment of any skin condition on their face/forearm/body.
  • 7.Subject allergic or sensitive to bar cleansing products, creams/lotions, artificial jewellery or anything else.
  • 8.Subject pregnant or nursing.
  • 9.Subjects taking medication including food supplements.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Significant improvement in acne condition by expert/dermatologist assessment4 weeks product and 1 week regression
Secondary Outcome Measures
NameTimeMethod
Significant improvement in other acne associated skin conditions4 weeks product and 1 week regression

Trial Locations

Locations (1)

MS Clinical Research Pvt. Ltd.

🇮🇳

Bangalore, KARNATAKA, India

MS Clinical Research Pvt. Ltd.
🇮🇳Bangalore, KARNATAKA, India
Dr Mukesh Ramnane
Principal investigator
08041125934
mukesh.ramnane@mscr.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.